Company / Operating Margin
Unicycive Therapeutics, Inc. Operating Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-3077.6%
FY2024
5-year range
-3077.6% / -944.0%
FY2022-FY2024
Trend
-62.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -944.0% to -3077.6% over the past 2 years.
Based on SEC 10-K filings.
-3077.6% in FY2024.
Declined from -944.0% to -3077.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 62.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -3077.6% | -62.1% |
| FY2023 | -1898.2% | -101.1% |
| FY2022 | -944.0% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026